Selective regulation of apoptosis: the cytotoxic lymphocyte serpin proteinase inhibitor 9 protects against granzyme B-mediated apoptosis without perturbing the Fas cell death pathway

Mol Cell Biol. 1998 Nov;18(11):6387-98. doi: 10.1128/MCB.18.11.6387.

Abstract

Cytotoxic lymphocytes (CLs) induce caspase activation and apoptosis of target cells either through Fas activation or through release of granule cytotoxins, particularly granzyme B. CLs themselves resist granule-mediated apoptosis but are eventually cleared via Fas-mediated apoptosis. Here we show that the CL cytoplasmic serpin proteinase inhibitor 9 (PI-9) can protect transfected cells against apoptosis induced by either purified granzyme B and perforin or intact CLs. A PI-9 P1 mutant (Glu to Asp) is a 100-fold-less-efficient granzyme B inhibitor that no longer protects against granzyme B-mediated apoptosis. PI-9 is highly specific for granzyme B because it does not inhibit eight of the nine caspases tested or protect transfected cells against Fas-mediated apoptosis. In contrast, the P1(Asp) mutant is an effective caspase inhibitor that protects against Fas-mediated apoptosis. We propose that PI-9 shields CLs specifically against misdirected granzyme B to prevent autolysis or fratricide, but it does not interfere with homeostatic deletion via Fas-mediated apoptosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Sequence
  • Apoptosis / physiology*
  • Caspase Inhibitors
  • Flow Cytometry
  • Humans
  • Microscopy, Fluorescence
  • Molecular Sequence Data
  • Recombinant Proteins / metabolism
  • Serpins / genetics
  • Serpins / pharmacology*
  • Serpins / physiology*
  • T-Lymphocytes, Cytotoxic / physiology*
  • Transfection / genetics
  • Tumor Cells, Cultured
  • fas Receptor / physiology

Substances

  • Caspase Inhibitors
  • Recombinant Proteins
  • SERPINB9 protein, human
  • Serpins
  • fas Receptor